The transaction also brought a $200 million investment for Sema4 from life science investors including Pfizer, which can help the combined company's goal of translating insights from genomics data and analytics into making precision medicine a standard of care.
A web-based analytical platform to tease apart genomic data just raised some cash: Utah-based genome analysis company Tute Genomics held a $2.3 million Series A1 round. Investors include Eurovestech, Peak Ventures and several angel investors, Tute Genomics said in a statement. The company’s cloud-base analytics platform is meant to be used by labs, clinicians and researchers […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.